THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqGM:RPRX) today announced results from an exploratory, efficacy and safety study of its oral investigational product, enclomiphene ...
The article by Grober et al. 1 provides valuable clinical information regarding the two Food and Drug Administration-approved formulations of testosterone (T) gels, Androgel and Testim. The authors ...
Administration of exogenous androgens and progestins suppress pituitary secretion of sex hormones and inhibit spermatogenesis, but only injectable or implantable testosterone had previously shown ...
A case that first appeared in a medical journal several years ago has recently resurfaced in the media, highlighting an unexpected risk of hormone therapies: a baby girl in Sweden developed unusually ...
Hip fractures, often a result of a fall, are the most serious type of osteoporotic fracture because they are accompanied by considerable pain, loss of muscle and bone strength, reduced mobility and ...
DEAR DR. ROACH: I am an 84-year-old male. I recently switched from testosterone patches to AndroGel. My testosterone levels have gone up considerably, and I have seen some improvement in my erectile ...
Active ingredient: Testosterone 10 mg/0.5 g actuation; metered-dose pump; topical gel. Indication: Primary hypogonadism. Hypogonadotropic hypogonadism. Pharmacology: Fortesta is a topical gel ...
Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...
Interested in elevating your vitality with hormonal supplements? Discover safe and legal Testosterone Gel options for sale in AU. Find top-quality hormone balance solutions, carefully curated to suit ...
NEW YORK (Reuters) - The U.S. Food and Drug Administration said on Thursday it will require strong warnings to be added to two testosterone replacement gel products after numerous reports of troubling ...
Daniel Kelly does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...